Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,6150816,plasma half-life,"The plasma half-life of indecainide after acute oral administration was 3-5 hr in rats, dogs, and monkeys but considerably shorter in mice.","The pharmacokinetics of indecainide in mice, rats, dogs, and monkeys. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/6150816/),h,3-5,156906,DB00192,Indecainide
,3351153,trough plasma level,The mean trough plasma level of indecainide on optimal dosage was 409 +/- 173 ng/ml and the mean plasma elimination half-life was 10.3 +/- 2.3 h (range 7.1 to 14.2).,"Indecainide for treatment of ventricular ectopic depolarizations: efficacy, pharmacokinetics, hemodynamic effects and safety. ",Ctrough-Q37,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3351153/),[ng] / [ml],409,159938,DB00192,Indecainide
,3351153,plasma elimination half-life,The mean trough plasma level of indecainide on optimal dosage was 409 +/- 173 ng/ml and the mean plasma elimination half-life was 10.3 +/- 2.3 h (range 7.1 to 14.2).,"Indecainide for treatment of ventricular ectopic depolarizations: efficacy, pharmacokinetics, hemodynamic effects and safety. ","t1/2,Î²-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3351153/),h,10.3,159939,DB00192,Indecainide
